Results 221 to 230 of about 48,625 (267)
Some of the next articles are maybe not open access.
Current Opinion in Endocrinology, Diabetes & Obesity, 2013
The aim of this study is to provide a thorough updated review of the diagnosis and treatment of postmenopausal osteoporosis.There have been several important findings in the field of postmenopausal osteoporosis over the past 1-2 years. Fewer morphometric vertebral fractures were found in women treated for 6 years with zoledronic acid compared with ...
Dima L, Diab, Nelson B, Watts
openaire +2 more sources
The aim of this study is to provide a thorough updated review of the diagnosis and treatment of postmenopausal osteoporosis.There have been several important findings in the field of postmenopausal osteoporosis over the past 1-2 years. Fewer morphometric vertebral fractures were found in women treated for 6 years with zoledronic acid compared with ...
Dima L, Diab, Nelson B, Watts
openaire +2 more sources
Current Osteoporosis Reports, 2004
The postmenopausal state is the most common underlying cause for osteoporosis and most of our understanding of the condition relates to this group. Recent evidence has suggested that hormone therapy may no longer have the pre-eminent place it once held but the same studies have also confirmed its antifracture efficacy. However, an increasing variety of
openaire +2 more sources
The postmenopausal state is the most common underlying cause for osteoporosis and most of our understanding of the condition relates to this group. Recent evidence has suggested that hormone therapy may no longer have the pre-eminent place it once held but the same studies have also confirmed its antifracture efficacy. However, an increasing variety of
openaire +2 more sources
Management of postmenopausal osteoporosis
European Journal of Obstetrics & Gynecology and Reproductive Biology, 1994More than 25% of postmenopausal women are at risk of osteoporosis. In order to avoid its consequences, it is necessary to find an appropriate prevention and/or treatment. We studied: (1) 15 postmenopausal women treated with percutaneous estradiol (50 micrograms/24 h) plus MPA (10 mg/10 days/month); (2) 15 postmenopausal women treated with synthetic ...
DI RENZO, Giancarlo +5 more
openaire +5 more sources
Southern Medical Journal, 1984
In 1980, the combined incidences of vertebral and hip fractures necessitating hospitalization of women living in Knox County, Tennessee nearly doubled each five years after the age of 50. These data led us to review the pathogenesis, diagnostic methods, and therapeutic measures used to control or minimize the occurrence of postmenopausal osteoporosis ...
A W, Diddle, I Q, Smith
openaire +2 more sources
In 1980, the combined incidences of vertebral and hip fractures necessitating hospitalization of women living in Knox County, Tennessee nearly doubled each five years after the age of 50. These data led us to review the pathogenesis, diagnostic methods, and therapeutic measures used to control or minimize the occurrence of postmenopausal osteoporosis ...
A W, Diddle, I Q, Smith
openaire +2 more sources
Postmenopausal osteoporosis and atheroma
Joint Bone Spine, 2006Epidemiological studies have established a significant association between two major health problems, osteoporosis and atheroma, which is independent from age, gender, and other cardiovascular risk factors. Bone loss and the development of calcific deposits within vessel walls occur concomitantly.
Gérald, Rajzbaum, Yvonnick, Bézie
openaire +2 more sources
Osteoporosis in postmenopausal women
The Journal of Prosthetic Dentistry, 1984Eleven postmenopausal complete denture patients participated in a study to evaluate some possible predictors of osteoporosis. Most participants in the study reported a low caloric intake and consumed considerably less than the recommended daily allowances of sodium, cholesterol, calcium, fluoride, magnesium, zinc, and folic acid.
R P, Renner, L J, Boucher, H W, Kaufman
openaire +2 more sources
Management of Postmenopausal Osteoporosis
Annual Review of Medicine, 2015A hallmark of menopause, which follows the decline in the ovarian production of estrogen, is the aggressive and persistent loss of bone mineral and structural elements leading to loss of bone strength and increased fracture risk. This review focuses on newer methods of diagnosing osteoporosis and assessing fracture risk, as well as on novel management
Panagiota, Andreopoulou +1 more
openaire +2 more sources
CALCITONIN AND POSTMENOPAUSAL OSTEOPOROSIS
Clinical Endocrinology, 1984SUMMARYFasting serum calcitonin levels were measured in 54 postmenopausal women who had for 10 years been taking part in a double blind trial to assess the effect of the synthetic oestrogen, mestranol, on postmenopausal bone loss. There were no differences in calcitonin levels between mestranol treated and placebo groups, Fifteen of the women were ...
J, Leggate +5 more
openaire +2 more sources
Treatment of Postmenopausal Osteoporosis
Comprehensive Therapy, 2007Osteoporosis is a skeletal disease characterized by low bone mass and microarchitectural deterioration with a resulting increase in bone fragility and hence susceptibility to fracture. Calcium and vitamin D are the most commonly used therapies for osteoporosis, although their efficacy in osteoporotic fracture prevention remains uncertain ...
Gayatri, Gupta, Wilbert S, Aronow
openaire +2 more sources
▼Denosumab for postmenopausal osteoporosis?
Drug and Therapeutics Bulletin, 2012Osteoporosis is the most common clinical disorder of bone metabolism, and is characterised by low bone mass and deterioration of the microarchitecture of bone tissue that results in increased bone fragility and susceptibility to bone fracture.1 In the UK, it is estimated that osteoporosis affects over 3 million people and leads to 230,000 fractures per
openaire +2 more sources